We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Medical Sciences/Current treatment of low grade gliomas
PeriodicalsMedical Sciences

Current treatment of low grade gliomas

Checking your access to this record.

Abstract & Overview

Low grade gliomas affect predominantly young adults, and have a relatively favorable prognosis compared to grade III and grade IV gliomas. The challenge for an optimal management of these patients is to find the balance between an optimal survival and the preservation of neurological function including cognition. Because all medical treatments may induce side effects, in young and nearly asymptomatic patients the choices can be difficult. This review summarizes the current strategies: a watch-and-wait policy, surgery, chemotherapy, and radiotherapy.

Cite this record

Martin J. van den Bent, Tom Jan Snijders, Jacoline E. C. Bromberg (2012). Current treatment of low grade gliomas. memo - Magazine of European Medical Oncology, 5(3), 223–227. https://doi.org/10.1007/s12254-012-0014-3

Copy in another style

Bent, M. J. V. D., Snijders, T. J., & Bromberg, J. E. C. (2012). Current treatment of low grade gliomas. memo - Magazine of European Medical Oncology, 5(3), 223–227. https://doi.org/10.1007/s12254-012-0014-3
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.